Researchers at University of Southern Alabama Release New Data on Amnesia (The Pattern of Dissociative Symptoms Differs Between Post-traumatic Stress Disorder and First Esketamine Administration for Treatment-resistant Depression).

The article focuses on research examining the differences in dissociative symptoms between patients with Post-Traumatic Stress Disorder (PTSD) and those undergoing their first treatment with esketamine for Treatment-Resistant Depression (TRD). Conducted by investigators at the University of Southern Alabama, the study found that while dissociative symptoms were more prevalent in the esketamine group, PTSD patients reported higher frequencies of dissociative amnesia and identity fragmentation. The research suggests that the etiology of dissociative symptoms may vary depending on the therapeutic context. Financial support for the study was provided by the National Institutes of Health, the Center for Naval Analysis, and the Department of Defense. [Extracted from the article]